DRUG discovery company Evotec has seen hopes of its anti-smoking drug disappear after a clinical trial.
The German company, which earlier this month declared nine redundancies at its laboratory at Milton Park, near Didcot, said the treatment failed to demonstrate any significant improvement in the quit rate compared with placebo.
Chief executive Dr Werner Lanthaler promised “strict cost containment”.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article